Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.534, 2007-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Proactive screening for chlamydia not worth it in the UK
Inpharma, Vol. 1, Iss. 1599, 2007-01 ,pp. :
Access to resources
Recommend
Is screening for type 2 diabetes mellitus worth it for the UK NHS?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 328, 2001-01 ,pp. :
Infliximab worth it for Crohn's disease in the UK
Inpharma, Vol. 1, Iss. 1515, 2005-01 ,pp. :
Influenza vaccination programme worth it in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. :
Screening for liver cancer worth it in cirrhosis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 407, 2003-01 ,pp. :